U.S. markets closed

Compugen Ltd. (CGEN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.00+0.59 (+7.96%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close7.41
Bid7.65 x 1100
Ask8.82 x 1000
Day's Range7.59 - 8.25
52 Week Range6.74 - 19.90
Avg. Volume1,428,287
Market Cap634.946M
Beta (5Y Monthly)2.31
PE Ratio (TTM)N/A
EPS (TTM)-0.37
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.29
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Compugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript
    Motley Fool

    Compugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript

    Before we begin, I would like to read the following regarding forward-looking statements. During the course of this conference call, the company may make projections or other forward-looking statements regarding future events or future business outlook, our development efforts and their outcome, our discovery platform, anticipated progress and timeline for our programs, financial and accounting related matters as well as statements regarding our cash position. The company undertakes no obligation to update projections or forward-looking statements in the future.

  • Why Compugen Stock Is Jumping Today
    Motley Fool

    Why Compugen Stock Is Jumping Today

    What happened Shares of Compugen (NASDAQ: CGEN) were jumping 7.9% as of 11:03 a.m. EDT on Thursday. The solid gain came after the drugmaker provided its first-quarter update before the market opened.  So what Today's solid uptick for the biotech stock likely had little to do with Compugen's Q1 financial results.

  • Compugen Reports First Quarter 2021 Results
    PR Newswire

    Compugen Reports First Quarter 2021 Results

    Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the first quarter ended March 31, 2021.